Please assess the completion status of the following clinical trial:

Trial Title: Renal Denervation for Resistant Hypertension

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* systolic BP ≥140mmHg or ≥130mmHg for patients with diabetes~* concurrent treatment with ≥3 anti-hypertensive drugs~Exclusion Criteria:~* renal artery anatomy ineligible for treatment~* eGFR \<15mL/min/1.73m2 (using Modification of Diet in Renal Disease (MDRD) calculation)~* female participants of childbearing potential must have negative pregnancy test prior to treatment

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 85 Years
- Healthy Volunteers: f

Study Arms:
- Renal Denervation Group (Type: EXPERIMENTAL): participants randomised to undergo the renal denervation procedure
- Usual care (Type: NO_INTERVENTION): participants randomised to the usual care group will receive additional antihypertensive medication in an attempt to achieve blood pressure targets

Based on this trial design, predict the completion outcome and termination type (if applicable).